← Back to Search

Retinol for Skin Aging

N/A
Waitlist Available
Research Sponsored by Johnson & Johnson Consumer Inc. (J&JCI)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
Has clinically active bacterial, fungi, or viral skin infection or has frequent skin infections
Has self-reported Type 1 or Type 2 diabetes or is taking insulin or another anti-diabetic medication
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (day 0), visit 3 (day 71)
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to determine if a method called skin tape stripping can show any changes in gene expression in older skin after using a retinoid.

Who is the study for?
This trial is for individuals with signs of skin aging or acne who are interested in testing a topical retinol product. Participants should not be currently using any night cream.
What is being tested?
The study aims to see if a non-invasive method called skin tape stripping can detect gene expression changes in aged or acne-affected skin after applying a retinol-based night cream.
What are the potential side effects?
Potential side effects may include skin irritation, redness, dryness, and peeling due to the use of retinol products.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I often get skin infections or currently have an active skin infection.
Select...
I have diabetes or am taking medication for diabetes.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (day 0), visit 3 (day 71)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (day 0), visit 3 (day 71) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Skin tape stripping.

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention CellExperimental Treatment1 Intervention
Investigational Night Cream plus auxiliary cleanser and sunscreen
Group II: No InterventionActive Control1 Intervention
Auxiliary cleanser and sunscreen only

Find a Location

Who is running the clinical trial?

Johnson & Johnson Consumer Inc. (J&JCI)Lead Sponsor
54 Previous Clinical Trials
5,521 Total Patients Enrolled
~40 spots leftby Feb 2025